Share

October 16, 2018; 91 (16) Video NeuroImages

Dermoskeletics to preserve mobility and function in inclusion body myositis

Océane Landon-Cardinal, François Prince, Stéphane Bédard, Olivier Benveniste, Marie Hudson
First published October 15, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006365
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
540

Share

Article Information

vol. 91 no. 16 760
DOI: 
https://doi.org/10.1212/WNL.0000000000006365
PubMed: 
30323070
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 15, 2018.
Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Océane Landon-Cardinal, MD,
    2. François Prince, PhD,
    3. Stéphane Bédard, PEng, MSc,
    4. Olivier Benveniste, MD, PhD and
    5. Marie Hudson, MD, MPH
  1. Océane Landon-Cardinal, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. François Prince, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Stéphane Bédard, PEng, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Patents: (1) Load Distribution Device for Human Joints ? B01, US 9,370,439, CA 2,803,035, EP 2555720. An IP protection on the dermoskeletal concept for any joint-segment body structure of the human body. This patent represents the core of the technological platform behind the B-Temia?s dermoskeletal technology. ▪ US. provisory deposit ? 7 April 2010. ▪ US Patent ? 21 June 2016. ▪ CA application ? 18 February 2011. ▪ EP Patent - 12 April 2017

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) B-Temia Inc., President and CEO, 2010

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) B-Temia Inc.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. (1) B-Temia Inc., 8 years

    Legal Proceedings:

    1. NONE

  4. Olivier Benveniste, MD, PhD and
    5. Scientific Advisory Boards:

    1. Csl Behring Novartis LFB

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) CSL Behring: funding for travel at the ACR 2014 conference (2) LFB: funding for travel at the ICNMD 2014 conference, ACR 2017

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Novartis (2) CSL Behring (3) Neovacs

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) LFB,(2) Novartis, (3) Shire, (4) CSL Behring, (5) Neovacs

    Research Support, Government Entities:

    1. (1) DGOS/INSERM, (2) PHRC

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) AFM, (2) The Myositis Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Marie Hudson, MD, MPH
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Hôpital Pitié-Salpêtrière (O.L.-C., O.B.), AP-HP, Department of Internal Medicine and Clinical Immunology, Inflammation-Immunopathology-Biotherapy Department (I2B), East Paris Neuromuscular Diseases Reference Center, Inserm U974, France; Departments of Kinesiology and Surgery (F.P.), University of Montreal, B-Temia Inc. (S.B.), Québec City, and Division of Rheumatology (M.H.), Department of Medicine, Jewish General Hospital, Lady Davis Institute, Montréal, Québec, Canada.
  1. Correspondence
    Dr. Landon-Cardinal o.landoncardinal{at}gmail.com
View Full Text

Article usage

Article usage: October 2018 to February 2023

AbstractFullPdfSource
Oct 20180114572Highwire
Nov 2018023126Highwire
Dec 2018010521Highwire
Jan 201958620Highwire
Feb 20192704Highwire
Mar 201914916Highwire
Apr 20191336Highwire
May 201914312Highwire
Jun 20190318Highwire
Jul 20191327Highwire
Aug 201904910Highwire
Sep 201905313Highwire
Oct 20191309Highwire
Nov 20191449Highwire
Dec 201925011Highwire
Jan 20200559Highwire
Feb 20200506Highwire
Mar 20201314Highwire
Apr 20200233Highwire
May 20200296Highwire
Jun 20201216Highwire
Jul 20201266Highwire
Aug 20200304Highwire
Sep 20202384Highwire
Oct 20200184Highwire
Nov 20201209Highwire
Dec 202012817Highwire
Jan 20210184Highwire
Feb 20210239Highwire
Mar 20210219Highwire
Apr 20212247Highwire
May 20210188Highwire
Jun 20210184Highwire
Jul 202111510Highwire
Aug 20211217Highwire
Sep 202102812Highwire
Oct 202101720Highwire
Nov 202102616Highwire
Dec 20210173Highwire
Jan 20220213Highwire
Feb 20221643Highwire
Mar 202203012Highwire
Apr 20221131Highwire
May 202201614Highwire
Jun 20220196Highwire
Jul 2022193Highwire
Aug 202211812Highwire
Sep 202201115Highwire
Oct 20221117Highwire
Nov 202203119Highwire
Dec 2022095Highwire
Jan 2023036Highwire
Feb 20230143Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles